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Contributions of tropodithietic acid and
biofilm formation to the probiotic activity
of Phaeobacter inhibens
Wenjing Zhao1,4, Christine Dao2,5, Murni Karim3,6, Marta Gomez-Chiarri3, David Rowley2 and David R. Nelson1*
Abstract
Background: The probiotic bacterium Phaeobacter inhibens strain S4Sm, isolated from the inner shell surface of a
healthy oyster, secretes the antibiotic tropodithietic acid (TDA), is an excellent biofilm former, and increases oyster
larvae survival when challenged with bacterial pathogens. In this study, we investigated the specific roles of TDA
secretion and biofilm formation in the probiotic activity of S4Sm.
Results: Mutations in clpX (ATP-dependent ATPase) and exoP (an exopolysaccharide biosynthesis gene) were
created by insertional mutagenesis using homologous recombination. Mutation of clpX resulted in the loss of TDA
production, no decline in biofilm formation, and loss of the ability to inhibit the growth of Vibrio tubiashii and Vibrio
anguillarum in co-colonization experiments. Mutation of exoP resulted in a ~60 % decline in biofilm formation, no
decline in TDA production, and delayed inhibitory activity towards Vibrio pathogens in co-colonization experiments.
Both clpX and exoP mutants exhibited reduced ability to protect oyster larvae from death when challenged by
Vibrio tubiashii. Complementation of the clpX and exoP mutations restored the wild type phenotype. We also found
that pre-colonization of surfaces by S4Sm was critical for this bacterium to inhibit pathogen colonization and
growth.
Conclusions: Our observations demonstrate that probiotic activity by P. inhibens S4Sm involves contributions from
both biofilm formation and the production of the antibiotic TDA. Further, probiotic activity also requires
colonization of surfaces by S4Sm prior to the introduction of the pathogen.
Keywords: Phaeobacter inhibens, Tropodithietic acid, Biofilm formation, Probiotic, Marine pathogens, Vibrio tubiashii,
Vibrio anguillarum, Oyster disease, ClpX, ExoP
Background
Infections by pathogenic marine bacteria are a major
problem for both the shellfish and finfish aquaculture in-
dustries, causing severe disease and high mortality,
which seriously affect aquaculture production and cause
significant economic loss [1]. This problem particularly
affects the survival and growth of fish and shellfish dur-
ing the larval and juvenile stages [1, 2]. Opportunistic
pathogens from the Vibrionaceae and at least one mem-
ber of the Roseobacter clade cause disease in a variety of
shellfish [3, 4]. For example, Vibrio tubiashii, a reemer-
ging pathogen of larval bivalve mollusks that causes
invasive and toxigenic disease, has been responsible for
massive mortalities among larval Pacific oysters (Crassos-
trea gigas) in hatcheries on the west coast of the United
States [4]. Additionally, Roseovarius crassostreae, a mem-
ber of the Roseobacter clade and the causative agent of ju-
venile or Roseovarius oyster disease (JOD or ROD), can
cause high mortalities in juvenile eastern oysters (Crassos-
trea virginica) in the northeastern United States during
the summer when water temperatures are ≥20 °C [5].
Although antibiotics and vaccines can be used to control
some infectious diseases in aquaculture, they have some
distinct disadvantages and limitations. Use of antibiotics
increases the risk of development and transfer of anti-
biotic resistance [6]. Vaccines, which rely on an adaptive
immune response, are only effective for vertebrate organ-
isms and cannot be used to protect shellfish [7].
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Probiotics represent a promising alternative strategy to
control infection and some probiotic strains are already
used commonly in aquaculture as biological control
agents in finfish and shellfish [8, 9]. For example, the
probionts Bacillus subtilis and Bacillus licheniformis are
widely used in shrimp aquaculture to provide beneficial
effects potentially including improved health and water
quality, control of pathogenic bacteria and their viru-
lence, stimulation of the immune system and improved
growth [10]. Several Phaeobacter species have been
shown to be effective probiotics for both finfish and
shellfish. For example, D’Alvise et al. [11] demonstrated
that Phaeobacter can be used as a probiotic treatment to
reduce the density of the fish pathogen Vibrio anguil-
larum in cultures of cod larvae, resulting in the reduc-
tion of mortality by vibriosis. The probiotic activity was
dependent upon the production of tropodithietic acid
(TDA) by P. gallaeciensis. Further, D’Alvise et al. [12]
demonstrated that a different TDA-producing strain of
Phaeobacter was able to reduce or eliminate V. anguil-
larum from a combined liquid-surface system. These and
other studies strongly suggest that antagonistic interac-
tions by probiotic bacteria against marine pathogens may
be useful in protecting commercially important species of
shellfish and finfish from infectious disease.
Phaeobacter inhibens is gram-negative α-Proteobacteria
from the Roseobacter clade. The Roseobacter clade, an
important member of the marine microbiota, ac-
counts for ~4 % to as much as ~40 % of bacterial
DNA from the ocean and plays an important role in
the organic sulfur cycle of the ocean [13–15]. Several
species in this clade exhibit inhibitory activity against
the growth of marine pathogens, including V. anguil-
larum, V. tubiashii and R. crassostreae [11, 12, 16].
Additionally, several potentially probiotic species from
the Roseobacter clade can be routinely isolated from
larval production facilities for turbot [17]. Further,
Phaeobacter species are typically excellent biofilm for-
mers, colonizing a variety of surfaces including the
walls of rearing tanks, microalgae, the skin of finfish,
and the shells of mollusks [12, 18, 19]. Although, bio-
film formation is thought to be essential for probiotic
activity by a variety of mechanisms including compe-
tition for adhesion sites, oxygen, nutrients, and by
preventing contact between pathogens and hosts [20],
the role of biofilm formation in the probiotic activity
of Phaeobacter species against shellfish pathogens has
not been thoroughly investigated.
Previously, we isolated P. inhibens S4 from the inner
shell surface of a healthy oyster [16]. This bacterium is a
short rod with 1–2 flagella on one or both poles. It has
pleiomorphic morphology and will elongate into long
rods and filaments under specific conditions (low salt
concentration, static incubation, stationary phase). It can
form rosettes and is an excellent biofilm former and a
dominant colonizer of surfaces in marine environments.
P. inhibens S4Sm is a spontaneous streptomycin-resistant
mutant of the parental S4. When S4Sm was used as a po-
tential probiotic treatment of oyster larvae, it showed
strong anti-pathogen activity and increased host survival
[16], but the actual mechanisms of probiotic activity used
by this isolate are not fully understood.
In this study we examined the roles of biofilm forma-
tion and TDA production in probiotic activity of P. inhi-
bens S4Sm in oysters challenged by the pathogen, V.
tubiashii. In order to determine the contributions of
TDA production and biofilm formation to the probiotic
activity of S4Sm, mutations in clpX (which blocks TDA
biosynthesis [21]) and an exopolysaccharide biosynthesis
gene (exoP) (potentially involved in biofilm formation)
were created by insertional mutagenesis. The effects of
these mutations upon TDA production, biofilm forma-
tion and probiotic activity were determined.
Results
P. inhibens S4Sm secretes the antibiotic tropodithietic acid
Bioassay-guided fractionation of P. inhibens supernatants
resulted in the purification of a single secondary metab-
olite possessing antimicrobial activity. The molecule was
identified as tropodithietic acid (TDA) based upon a
molecular ion of [M +H]+ = 213 [13] and comparison of
1H NMR chemical shift data (500 MHz, C6D6) with lit-
erature values [22] (Additional files 1, 2 and 3). All as-
says described below were conducted with this purified
TDA. UHPLC analysis data (Fig. 1a) confirmed that
TDA was present in S4Sm supernatant.
Differential sensitivities of marine pathogens to TDA
We examined the relative sensitivities of three pathogens
of marine organisms, V. anguillarum NB10Sm, V. tubia-
shii RE22Sm, and R. crassostreae CV919Sm, to P. inhi-
bens S4Sm by looking at the inhibition of growth around
a colony of S4Sm. V. anguillarum NB10Sm was most
sensitive to S4Sm with largest zone of inhibition (ZOI)
(diameter = 12.5 ± 0.5 mm); R. crassostreae exhibited
slightly less sensitivity to S4Sm (ZOI =11.2 ± 0.3 mm);
and the least sensitive pathogen to S4Sm was V. tubia-
shii RE22Sm (ZOI = 9.2 ± 0.6 mm) (Fig. 1b). These data
were consistent with the results for minimum inhibitory
concentration (MIC) of TDA against each of the three
pathogens: the MIC for TDA against NB10Sm was
1.25 μg/ml, against R. crassostreae the MIC was 5 μg/ml,
and against RE22Sm the MIC was 6.25 μg/ml.
Biofilm formation by P. inhibens S4Sm
S4Sm formed thick biofilms on glass, as determined
using the crystal violet staining assay. The OD580 value
for the S4Sm biofilm after 60 h was ~4.0 at 27 °C under
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static conditions (Table 1). In contrast, all three marine
pathogens (V. anguillarum, V. tubiashii, and R. crassos-
treae) used in this study formed biofilms that were be-
tween 13.4-14.9 % of the S4Sm (Table 3) (P < 0.05). These
data suggested that S4Sm was able to form a thick, dense
biofilm matrix on glass coverslips and tubes.
Effect of clpX gene mutation on TDA production
In order to examine the roles of TDA production and
biofilm formation in the probiotic activity of S4, we con-
structed mutations in the tdaA, tdaB, and tdbD, genes,
previously shown to be part of the TDA biosynthesis
pathway [21]. These mutants not only lost TDA production,
but also were defective for biofilm formation (Additional
file 4). To differentiate the roles of TDA production and
biofilm formation in probiotic activity in oysters, we con-
structed mutants deficient in either TDA synthesis or bio-
film production. It was previously shown that mutation in
clpX resulted in the loss of TDA production in Phaeobac-
ter sp. strain 27–4 [21]. The clpX gene was PCR amplified
and sequenced. The derived amino acid sequence was
compared (using BLASTx) to other clpX genes already
available for Phaeobacter strains in the non-redundant
protein GenBank database. The S4Sm ClpX protein has
100 % identity to other P. inhibens ClpX proteins. The
clpX gene was found to encode a 408 amino acid ATP-
dependent protease ATP-binding subunit and is part of the
ClpXP multimer (Accession number: WP_014874379).
Mutation of clpX by insertional mutagenesis resulted in the
loss of TDA production. UHPLC analysis data (Fig. 1c)
showed that no TDA was present in clpX mutant super-
natant. Further, there were no inhibition zones around the
clpX mutant cells when tested against the three pathogens,
V. anguillarum NB10Sm,V. tubiashii RE22Sm, and R. cras-
sostreae CV919Sm (Fig. 1b). Additionally, culture super-
natant from the clpX mutant was not able to kill NB10Sm
cells (Table 2). Complementation of the clpX gene restored
TDA production (Fig. 1c) and anti-Vibrio activity (Fig. 1b
and Table 2). Mutation of clpX did not result in defective
biofilm formation (Table 1). The clpX mutant and the clpX
complement exhibited the same growth rate and final cell
density as the wild type when grown in YP30 under shaking
and static conditions (Additional file 5).
Effect of exoP gene mutation on biofilm formation
In order to develop a strain of S4 defective in biofilm
formation but able to produce TDA, the exoP gene,
which encodes an exopolysaccharide biosynthesis do-
main protein (based on Tigrfam classification systems),
was identified in P. inhibens S4Sm strain. Mutation of
exoP resulted in decreased biofilm formation, with the
exoP mutant exhibiting only ~40 % of the wild type level
of biofilm formation (Table 1) (P < 0.05). Complementa-
tion of exoP gene restored biofilm formation to wild type
level (Table 1). Mutation of exoP did not result in defect-
ive TDA production (Fig. 1b). The exoP mutant and the
exoP complement exhibited the same growth rate and
(See figure on previous page.)
Fig. 1 Reversed-phase HPLC chromatograms of ethyl acetate extracts from Phaeobacter strains to detect TDA. a Authentic TDA and extract from
wild type strain S4Sm. b Inhibition zone assay of S4Sm, clpX mutant (clpX-), clpX complement (clpX+), exoP mutant (exoP-) or exoP complement
(exoP+) on YP30 plates coated by V. anguillarum (NB10Sm), V. tubiashii (RE22Sm) or R. crassostreae (CV919Sm) after 24 h at 27 °C. c Authentic TDA
and extracts from clpX mutant strain (clpX-), clpX complement (clpX+), exoP mutant strain (exoP-), exoP complement (exoP+). The data presented
are averages of two independent experiments and each independent experiment has three replicates. Error bars represent one
standard deviation
Table 1 Quantification of biofilm formation by measuring
optical density at 580 nm (OD580) of crystal violet dye attached
to the cells forming biofilms on glass tubes at 27 °C under static
conditions at 60 h
Strains OD580 (±SD)
a
P. inhibens S4Sm 3.89 ± 0.06
P. inhibens WZ10 (clpX-) 3.90 ± 0.12
P. inhibens WZ11 (clpX+) 4.0 ± 0.06
P. inhibens WZ20 (exoP-) 1.60 ± 0.09b
P. inhibens WZ21 (exoP+) 3.90 ± 0.10
V. anguillarum NB10Sm 0.58 ± 0.02b
V. tubiashii RE22Sm 0.54 ± 0.02b
R. crassostreae CV919Sm 0.52 ± 0.08b
aBiofilm formation quantified by crystal violet dye assay as described in the
Materials and Methods. The data presented are the average of two
independent experiments, each with three replicates. SD = standard deviation
bStatistically significant difference (P <0.05) compared to S4Sm
Table 2 Killing ability of culture supernatant of various P.
inhibens strains against V. anguillarum NB10Sm cellsa
Treatment Surviving V. anguillarum cell density
(CFU/ml) after the treatment (±SDb)
NSSc (negative control) 40.7 (±3.8) × 107
S4Sm culture supernatant <10
WZ10 (clpX-) culture supernatant 41.3 (±1.5) × 107
WZ11 (clpX+) culture supernatant <10
WZ10 (clpX-) culture supernatant plus TDA <10
WZ20 (exoP-) culture supernatant <10
WZ21 (exoP+) culture supernatant <10
aCulture supernatant from each strain collected after two-day incubation. The
data presented are from a representative experiment of two
independent experiments
bSD = standard deviation
cNSS: Nine salts solution
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final cell density as the wild type when grown in YP30
under shaking and static conditions (Additional file 5).
Effect of clpX and exoP mutations on the ability of P.
inhibens biofilms to antagonize colonization of coverslips
by Vibrio species
The clpX mutant (no TDA production and normal biofilm)
and the exoP mutant (normal TDA production and reduced
biofilm) allowed us to examine the relative roles of biofilm
formation and TDA production on the ability of 24 h bio-
films of S4Sm to: 1) antagonize colonization of glass sur-
faces by V. tubiashii RE22Sm and 2) decrease the cell
density (CFU/ml) of the pathogen in the liquid culture
media. When a co-colonized glass coverslip was examined
after 72 h of incubation by laser scanning confocal micros-
copy, more RE22Sm cell clusters were observed in the bio-
film matrix of the clpX mutant than in the biofilm matrix of
either S4Sm wild type or exoP (Fig. 2a). These observations
were reflected in the viable cell counts of the V. tubiashii
RE22Sm in both biofilms (sessile cells; Fig. 2b) and in sus-
pension (planktonic cells; Fig. 2c) when grown in the pres-
ence of biofilms of P. inhibens S4Sm wild type, the clpX
mutant or the exoP mutant. For example, as shown in
Fig. 2b at 123 h, the number of viable RE22Sm in the
A
B
C
Fig. 2 Competition assay between OFP-labeled P. inhibens S4 strains and GFP-labeled V. tubiashii. P. inhibens stains were allowed to grow and
form biofilms on the glass surfaces for 24 h before the addition of V. tubiashii RE22Sm-GFP. The mixed cultures are S4Sm-OFP with RE22Sm-GFP,
clpX-OFP with RE22Sm-GFP and exoP-OFP with RE22Sm-GFP. a Merged confocal microscopy images of mixed biofilm development by OFP-producing
strains (S4Sm, clpX mutant and exoP mutant) and GFP-producing V. tubiashii (RE22Sm) strain on the surface of glass coverslip at 72 h. The data
presented are from a representative experiment of two independent experiments. b Growth of sessile P. inhibens S4Sm strains (S4Sm, clpX, and exoP)
and V. tubiashii RE22Sm in a co-culture system. c Growth of planktonic P. inhibens S4Sm strains (S4Sm, clpX, and exoP) and V. tubiashii RE22Sm in a co-
culture system. The data presented are average of two independent experiments and each independent experiment has three replicates. Error bars
represent one standard deviation
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biofilm on a coverslip was 1 × 104 CFU when precolonized
with S4Sm. In contrast, the number of RE22Sm cells in-
creased 180-fold (to 1.8 × 106 CFU/coverslip) when grown
in the presence of the clpX mutant. This was about the
same number of cells on a coverslip as when RE22Sm was
allowed to colonize alone (2.0 × 106 CFU/coverslip). Further,
when grown in the presence of the exoPmutant the number
of viable RE22Sm cells on the coverslip was 4.5-fold higher
(4.5 × 104 CFU/coverslip) than in the presence of S4Sm cells
(1 × 104 CFU/coverslip) (Fig. 2b). This is a significant differ-
ence in RE22Sm biofilm formation (P < 0.05). In suspension,
the cell density of RE22Sm reached 2 × 108 CFU/ml under
conditions of precolonization by the clpX mutant; this was
similar to the density of RE22Sm grown alone (1.8 ×
108 CFU/ml), but about two orders of magnitude higher
than when RE22Sm was co-cultured with either S4Sm
(3.1 × 106 CFU/ml) or exoP (2.6 × 106 CFU/ml) at 123 h
(Fig. 2c, P < 0.05). These data showed that the clpX mutant
was not able to inhibit RE22Sm growth or biofilm formation
under the tested conditions. While the exoP mutant was
able to inhibit RE22Sm biofilm formation to the same ex-
tent as the wild type S4Sm, the exoP mutant showed de-
creased ability to inhibit RE22Sm planktonic growth.
Effects of exogenous TDA on the antagonistic activity of
the clpX mutant
In order to confirm the relationship between the loss of
TDA production and the inability of the clpX mutant bio-
film to block colonization by the tested pathogens, ex-
ogenous TDA (10 μg/ml) or the same volume of distilled
water (no extra TDA added) was added to the co-culture
system of the clpX mutant (TDA deficient) and RE22Sm
at the same time as the pathogens. Addition of TDA sup-
pressed biofilm formation (Fig. 3a, by ~102 to 103 fold)
and planktonic growth (Fig. 3c, by >104 fold) by RE22Sm
cells for 24 h. This was seen in mixed cultures of RE22Sm
plus either S4Sm or the clpX mutant or in the monocul-
ture of RE22Sm. Further, the number of RE22Sm cells in
all three TDA-supplemented cultures, whether as biofilms
or planktonic cells, was not statistically different. However,
the effects of a single dose of exogenous TDA were transi-
tory. At 48 h, the amount of RE22Sm cells co-cultured
with the clpX mutant and exogenous TDA increased over
160-fold, and were not significantly different from the
values for RE22Sm cultured alone (Fig. 3a and c). The
confocal micrographic images of biofilms from 48 h cul-
tures confirmed that more RE22Sm cells (green) were ob-
served in the clpX mutant biofilm (with exogenous TDA)
than in S4Sm biofilm (Fig. 3b).
Effects of V. tubiashii on growth of P. inhibens strains in
competition assays
In order to see if V. tubiashii would affect the growth of
our various P. inhibens strains, we compared the growth
of P. inhibens strains in the presence of V. tubiashii with
growth in monoculture controls. Growth of wild type
S4Sm and the exoP mutant were not affected by V.
tubiashii on the coverslip (Fig. 4a, left and right panels,
respectively) or in suspension (Fig. 4b, left and right
panels, respectively). In contrast, the growth of the clpX
mutant was affected by V. tubiashii. At each time point
tested, the density of the clpX mutant (grown with
RE22Sm) was lower than that of the monoculture con-
trol (Fig. 4a & b, center panels). For example, at 72 h the
biofilm density of clpX mutant cells grown in the pres-
ence of RE22 was 13.2 % of clpX mutant cells grown
axenically (3.3 × 106 ± 5.3 × 105 CFU/coverslip vs. 2.5 ×
107 ± 1.2 × 106 CFU/coverslip, P < 0.05). Similarly, the
planktonic cell density of clpX mutant cells grown in the
presence of RE22Sm was 13.5 % of clpX mutant cells
grown axenically (3.1 × 107 ± 6.0 × 106 CFU/ml vs. 2.3 ×
108 ± 6.9 × 107 CFU/ml, P < 0.05). Additionally, when V.
anguillarum NB10Sm was co-cultured with either S4Sm
or the exoP mutant, it did not affect their growth; how-
ever, NB10Sm did inhibit the growth of the clpX mutant
(Additional file 6).
Effects of co-incubation with Phaeobacter strains on
pathogen growth and biofilm formation
To determine if P. inhibens S4Sm can compete against Vib-
rio pathogens when added at the same time, competition
assays were performed (Fig. 5). The amount of RE22Sm
cells in the biofilm was ~8.3 × 107 CFU/coverslip at 48 h
(Fig. 5a). This was 830-fold more RE22 cells than detected
in the biofilm which was pre-colonized with S4Sm for 24 h
(1 × 104 CFU/coverslip; Fig. 2b). Similarly, without pre-
colonization by the P. inhibens mutants (clpX or exoP mu-
tants) RE22Sm exhibited 10- to 100-fold more cells in the
mixed biofilm compared to biofilms formed with pre-
colonization by the P. inhibens mutants (for exoP: the
amount of RE22Sm with pre-colonization is ~1 × 105 CFU/
coverslip, without pre-colonization ~1.1 × 107 CFU/cover-
slip; for clpX: with pre-colonization ~ 1.2 × 106 CFU/cover-
slip, without pre-colonization ~ 1.0 × 107 CFU/coverslip)
(Fig. 2b, Fig. 5a). Further, when S4Sm was added at the
same time as the pathogen, cell density of planktonic
RE22Sm (at 48 h) was ~ 9.3 × 108 CFU/ml (Fig. 5b), more
than 30-fold higher than the density of RE22Sm observed
in the pre-colonized culture (2.8 × 107 CFU/ml) (Fig. 2d).
In contrast, pre-colonization with S4Sm was not necessary
to antagonize V. anguillarum (NB10Sm). In experiments
where S4Sm and NB10Sm were inoculated together,
NB10Sm was eliminated from both the coverslip biofilm
and the liquid culture by 40 to 48 h (Additional file 7). Fur-
ther, the exoP mutant inhibited NB10Sm biofilm formation
and growth in suspension almost as well as S4Sm. In con-
trast, the clpX mutant (TDA deficient) exhibited almost no
inhibition of either biofilm formation or planktonic growth
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of NB10Sm, compared to NB10Sm grown alone. These ob-
servations are also illustrated by the confocal images of bio-
films formed by OFP-tagged P. inhibens strains and GFP-
tagged NB10Sm (WZ203) cells (Additional file 7).
Effect of mutations in clpX and exoP on probiotic activity
of P. inhibens against V. tubiashii in oyster larvae
In order to determine if mutations in TDA production
or biofilm formation would affect the probiotic activity
Fig. 3 Effects of TDA supplementation on competition assays between P. inhibens strains and V. tubiashii RE22Sm. a Growth of sessile RE22Sm on
a glass coverslip in co-culture with either the S4Sm wild type or the clpX mutant strain (WZ10) supplemented with or without TDA (10 μg/ml).
b Single channel and merged confocal microscopy images of mixed biofilm development by OFP-producing strains of P. inhibens S4Sm (WZ02)
or the clpX mutant (WZ12) with the GFP-producing strain of V. tubiashii RE22Sm (WZ103) on the surface of a glass coverslip at 48 h after addition
of RE22Sm and TDA. c Growth of planktonic RE22Sm in co-culture system with either the S4Sm wild type or the clpX mutant strain supplemented
with or without TDA (10 μg/ml). The data presented are averages of two independent experiments with each experiment done in triplicate. Error
bars represent one standard deviation
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AB
Fig. 4 Effects of V. tubiashii on the growth of P. inhibens strains in a competition assay. P. inhibens S4Sm strains were allowed to grow and form
biofilms for 24 h before the addition of V. tubiashii RE22Sm. The mixed cultures are: S4Sm-OFP with RE22Sm-GFP, clpX-OFP with RE22Sm-GFP and
exoP-OFP with RE22Sm-GFP. a Growth of sessile S4 cells (with RE22Sm) in a co-culture system and a monoculture control. b Growth of planktonic
S4 cells (with RE22Sm) in a co-culture system and a monoculture control. The data presented are averages of two independent experiments with
each experiment done in triplicate. Error bars represent one standard deviation
A
B
Fig. 5 Competition between P. inhibens S4Sm strains and V. tubiashii RE22 without pre-colonization by P. inhibens. The mixed cultures are: S4Sm-OFP
with RE22Sm-GFP, clpX-OFP with RE22Sm-GFP, and exoP-OFP with RE22Sm-GFP. a Growth of sessile S4 strains and RE22Sm in a co-culture system.
b Growth of planktonic S4 strains and RE22Sm in a co-culture system. The data presented are averages of two independent experiments with each
experiment done in triplicate. Error bars represent one standard deviation
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of S4Sm against V. tubiashii in vivo, larval oyster challenge
assays were performed as described by Karim et al. [16]. P.
inhibens mutants showed a significant reduction in their
ability to protect larval oysters against V. tubiashii challenge
compared to wild type S4Sm (Fig. 6). The clpX mutant ex-
hibited a >50 % decline in oyster larvae survival compared
to S4Sm (S4Sm: 72.4 % ± 1.4 % vs. clpX: 35.7 % ± 3.3 %, P <
0.05), while the exoP mutant provided almost 70 % of
the protection as S4Sm (S4Sm: 72.4 % ± 1.4 % vs. exoP:
50.6 % ± 8.3 %, P <0.05) (Fig. 6). Thus, both P. inhibens
mutants still provided partial protection. Survival in larvae
pretreated with either the clpX or exoP mutant (35.7 % ±
3.3 % and 50.6 % ± 8.3 %, respectively) was signifi-
cantly higher than the survival of larvae treated only with
RE22 (20.3 % ± 1.9 %, P < 0.05) (Fig. 6).
Discussion
Several Phaeobacter species are known to have probiotic
activity and are able to protect fish species against bacter-
ial pathogens [11]. The production of the broad-spectrum
antibiotic, tropodithietic acid (TDA), is regarded as one of
the major factors contributing to probiotic activity against
V.anguillarum infection in turbot and cod [11]. We re-
cently reported that the new isolate P. inhibens S4Sm pro-
tects the Eastern oyster (Crassostrea virginica) from
infection by two oyster pathogens, V. tubiashii and R.
crassostreae [16]. In this report, we dissect the roles of
TDA biosynthesis and biofilm formation in promoting
probiotic activity by P. inhibens S4Sm, showing that both
mechanisms are involved.
Although the TDA biosynthetic pathway has not been
fully elucidated, many of the genes required for the for-
mation of TDA and much of the pathway have been
discovered [21, 23, 24]. One gene reported to be in-
volved in TDA biosynthesis is clpX (encoding ClpX)
[21]. ClpX is an AAA+ ATPase that functions as an
unfoldase chaperon for ClpP (ATP-dependent protease)
and with ClpP forms the multimeric ClpXP protease
[25]. An insertional mutation in the clpX gene specific-
ally blocked the biosynthesis of TDA in S4Sm (Fig. 1a)
without affecting biofilm formation (Table 1) or growth
(Additional file 4). Further, the effects of mutations to
clpX upon cell physiology are subtle and diverse [26–28].
In contrast, mutations in tdaA, tdaB, and tdbD, all block
TDA biosynthesis and also affect biofilm formation in
S4Sm. The mechanism by which ClpX affects TDA pro-
duction is still unknown. Additionally, the reasons why
mutations in tdaA, tdaB, and tdbD decrease biofilm for-
mation, as well as TDA biosynthesis, are not understood,
and are not the focus of this study.
The clpX TDA deficient mutant was unable to inhibit V.
tubiashii growth in either liquid or as a biofilm on a glass
coverslip (Fig. 2); however, when cultures were supple-
mented with TDA, the growth of planktonic V. tubiashii
growth was inhibited (Fig. 3). It is well known that organ-
isms in biofilms are more resistant to antibiotics than
when suspended in liquid [29]. This is consistent with our
data showing that TDA antibiotic activity was more po-
tent against planktonic RE22 cells than towards RE22 cells
living in a biofilm. These data, in which the effect of the
wild type was restored by adding TDA to the clpX anti-
biotic activity mutant, strongly suggest that the loss of
TDA production is responsible for the defect in antagonis-
tic activity in the clpX mutant. Further, 48 h after the
addition of TDA into the co-culture the inhibitory effect
of TDA disappeared, likely due to instability of TDA over
time or metabolism by V. tubiashii. Except for the loss of
TDA synthesis, the clpX mutant exhibited no other de-
fects in growth or biofilm formation compared to the
S4Sm wild type when grown in pure culture (Additional
file 5). The results reported here confirm the role of TDA
as an antibiotic promoting probiotic activity of Phaeobac-
ter species described previously by D’Alvise et al. [11] in
another host-pathogen system. It is interesting to note
that the growth of the clpX mutant is depressed by RE22
(Fig. 2), suggesting that TDA production allows P.
inhibens to compete with faster growing species for
available nutrients.
P. inhibens, a member of the abundant marine Roseobac-
ter clade, is known to be an excellent colonizer of environ-
mental surfaces [23]. While no study of the effects of
biofilm formation on the probiotic mechanism of Phaeo-
bacter has been reported, it is interesting to note that Prol
Garcia et al. (2014) recently reported that biofilm formation
is not a prerequisite for TDA formation in P. inhibens. In
that study, the authors, using Tn5 transposon mutagenesis,
identified 22 TDA-positive mutants with defects in biofilm
Fig. 6 Oyster larvae survival in the presence of P. inhibens strains after
challenge with V. tubiashii. The P. inhibens S4Sm strains (1 × 104 CFU/ml)
were introduced 24 h before larvae were challenged with V. tubiashii
RE22Sm (1 × 105 CFU/ml). Oyster larvae treated only with artificial
seawater served as control (mock). Oyster larvae survival (% ±SD) was
determined 24 h after challenge with RE22Sm Bars marked with an
asterisk (*) show significant differences (p <0.05). Representative of at
least 3 experiments. Error bars represent one standard deviation
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formation. Among classes of genes identified as contri-
buting to biofilm formation were those involved in exopoly-
saccharide formation. In our study, the exoP gene was
identified in S4Sm (using RAST [30]) as an exopolysacchar-
ide biosynthesis gene, which is thought to be involved in
biofilm formation. Mutation of exoP resulted in a large de-
crease in biofilm formation (Table 1), and exhibited no
other defects in growth or TDA formation (Fig. 1c and
Table 2). Thus, our observations correspond to those re-
ported by Prol Garcia et al. (2014) that biofilm formation is
not a prerequisite for TDA production and also that muta-
tion of a gene involved with exopolysaccharide production
can affect biofilm formation. While the exoP mutant was
modestly defective in its ability to inhibit Vibrio species in
competition assays (Figs. 2 & 5) it did exhibit significantly
decreased probiotic activity in the oyster challenge assay
against V. tubiashii (Fig. 6), these declines were less than
those seen in the clpX mutant. We suggest that while in the
in vitro (glass coverslip) model the exoP mutant forms
much less biofilm than the wild type, enough TDA accu-
mulates to inhibit RE22 to levels near those caused by wild
type cells. However, in the in vivo oyster challenge model,
the reduced biofilm of the exoP mutant results in decreased
TDA production that is diluted by the larger volumes of the
system and the feeding activity of the oyster larvae causing
less inhibition of RE22. These data suggest that biofilm for-
mation contributes to the probiotic activity of S4Sm. Bio-
films may contribute to probiotic activity in two ways. First,
biofilms would allow P. inhibens to physically occupy poten-
tial sites of colonization and prevent the oyster pathogens
from gaining access to the oyster. Second, the formation of
an extensive biofilm with cells at high density may induce
the production of TDA [31]. A more extensive biofilm
would produce more TDA and, therefore, more effectively
inhibit the ability of pathogens to infect the oyster host.
As a broad spectrum antibiotic TDA inhibits the growth
of several marine pathogens [32]. However, in the ocean
environment TDA will be rapidly diluted once it is se-
creted. We suggest that P. inhibens requires both TDA
production and biofilm formation for effective probiotic
activity. The biofilm matrix creates a microenvironment
within which TDA can accumulate to reach concentra-
tions high enough to inhibit pathogens. In the absence of
TDA, a P. inhibens biofilm does not eliminate pathogens
and provides only modest protection against disease. Fur-
ther, P. inhibens growing with a diminished biofilm also
exhibits significantly reduced probiotic activity probably
due to the decreased mass of cells producing TDA and
the increase in available sites for pathogens to colonize.
Our data indicate that maximum probiotic activity re-
quires both TDA production and biofilm formation.
Karim et al. [16] reported that oyster larvae were best
protected when P. inhibens S4Sm was added 24 h prior
to challenge by either of the two oyster pathogens, V.
tubiashii and R. crassostreae. The data presented in this
report is consistent with those previous observations
and reveal that pre-colonization of a surface by S4Sm is
more effective than co-incubation at inhibiting V. tubia-
shii RE22 from either colonizing the glass coverslip sur-
face or from growing planktonically (Figs. 2 and 5). One
potential reason for this need for a 24 h pre-treatment is
the rapid generation time of Vibrio species in YP30 (at
27 °C, with shaking), which is less than 1 h (V. tubiashii
is ~0.53 h,V. anguillarum is ~0.89 h), while the doubling
time for P. inhibens S4Sm is ~3.1 h. Successful probiotic
activity by S4Sm may be dependent upon growth rate
and having enough TDA producing cells in the biofilm
to successfully antagonize and out-compete the oyster
pathogens. Interestingly, we show in our study that V.
anguillarum cells are more sensitive to TDA than are V.
tubiashii cells, and that, while pre-colonization of sur-
faces by S4Sm was required to prevent the colonization
of coverslips by V. tubiashii, it was not required to prevent
the colonization by V. anguillarum. Consistent with these
observations, D’Alvise et al. [11] showed that it was not
necessary for P. gallaeciensis to precolonize the wells con-
taining cod larvae in order to antagonize V. anguillarum
and significantly reduce cod larvae mortalities. Our exper-
iments indicate differences between Vibrio species on how
they interact with the S4Sm probiotic. Interestingly, pre-
colonization with RE22 reduces the ability of S4 and mu-
tants to grow & colonize glass cover slips and to grow
planktonically (Fig. 5), suggesting that RE22 is able to
modulate the probiotic activity of S4Sm through negative
impacts on the ability to grow and/or colonize surfaces.
Conclusions
The results presented in this study demonstrate that both
TDA production and biofilm formation contribute to the
probiotic activity of P. inhibens S4Sm. Specifically block-
ing TDA production by mutation of the clpX gene re-
sulted in a significant decline in probiotic activity as
determined by coverslip colonization assay or by survival
of oyster larvae challenged by V. tubiashii RE22. While re-
ducing biofilm formation by mutation of the exoP gene
also resulted in a significant decline in probiotic activity as
determined by survival of oyster larvae challenged by V.
tubiashii RE22, but only a modest decline as measured by
coverslip colonization assay. It is possible that biofilm for-
mation contributes to probiotic activity in two ways: 1) oc-
cupying potential colonization sites and 2) increasing cell
density-dependent induction of TDA biosynthesis. Future
investigation will examine these possibilities.
Methods
TDA purification, identification and detection
TDA was produced and extracted using a modified
method of Bruhn et al. [13]. P. inhibens S4Sm was
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cultured in 7 x 1 L volumes of YP30 culture medium at
27 °C with shaking at 175 rpm. After 96 h, the cells were
pelleted by centrifugation at 10,000 rpm for 10 min. The
resulting culture supernatants were acidified to pH 3 with
formic acid (FA) and extracted with acidified (0.1 % FA)
ethyl acetate. The organic fraction was concentrated in
vacuo to yield 0.673 g of crude extract. The extract was
fractionated using C18 flash chromatography (Redisep Rf
high performance gold 30 g hp combiflash column; linear
gradient elution 5 % - 100 % CH3OH in H2O, 0.1 % FA,
35 ml/min, 45 min). Fractions containing TDA (tR =
15 min) were further purified by reversed-phased HPLC
(Xterra 5 μm C18 100 x 3.0 mm column, 0.5 ml/min, 5 %
to 100 % CH3OH in H2O over 24 min). Pure TDA
(10 mg) was identified based on comparison of 1H NMR
(Varian 500 MHz spectrometer) and mass spectral data in
comparison to previously reported values (Additional
files 1, 2 and 3) [22]. All assays were conducted with puri-
fied TDA from P. inhibens S4Sm.
Culture supernatants from P. inhibens wild type and
mutant strains were analyzed by HPLC for the presence
of TDA. P. inhibens strains were cultivated in 50 ml
YP30 broth until stationary phase (2 × 109 CFU/ml).
Cells were pelleted by centrifugation (5000 × g, 10 min)
and extracted as described above. The resulting organic
extracts were reconstituted as 10 mg/ml solutions in
methanol. Chromatography was performed on a Hitachi
LaChromUltra UHPLC equipped with a Fortis C18
UHPLC Column (1.7 μm, 2.1 x 50 mm). Method:
0.25 ml/min flow rate, 5 % CH3OH in H2O (both acid-
ified with 0.1 % FA) for 1 min, linear gradient to 100 %
CH3OH over 6.2 min, 100 % CH3OH for 2 min.
Minimum inhibitory concentrations of TDA against V.
anguillarum, V. tubiashii, and R. crassostreae
The minimal inhibitory concentrations (MIC) of TDA
against selected marine pathogens were determined
using a broth dilution method in microtiter plates [33].
Overnight bacterial cultures were diluted to 105 CFU/ml
in YP30 and treated with serial dilutions of pure TDA.
After 24 h incubation at 27 °C, MICs were determined
as the lowest concentration where there was no visible
growth. Two independent experiments were done and
each independent experiment had three replicates.
Bacterial strains, plasmids, and growth conditions
All bacterial strains and plasmids used in this report are
listed in Table 3. P. inhibens strains were routinely
grown in yeast extract (0.5 %)-peptone (0.1 %) broth plus
3 % sea salts, pH 7.6 (YP30) [16], supplemented with the
appropriate antibiotic, in a shaking water bath (175 rpm)
at 27 °C. Overnight cultures (2 × 109 CFU/ml) of P. inhi-
bens, grown in YP30, were harvested by centrifugation
(8000 × g, 2 min) and the pelleted cells were washed
twice with nine-salt solution (NSS) [34]. Washed cells
were resuspended to appropriate cell densities in experi-
mental media. Cell densities were estimated by optical
density at 600 nm (OD600) and more accurately deter-
mined by serial dilution and spot plating. Specific condi-
tions for each experiment are described in the text.
Escherichia coli strains were routinely grown in Luria-
Bertani broth plus 1 % NaCl (LB10) [35]. Vibrio anguil-
larum strains were routinely grown in LB20 at 27 °C
[36]. V. tubiashii and R. crassostreae strains were routinely
grown in YP30 at 27 °C [16]. Antibiotics were used at the
following concentrations: streptomycin, 200 μg/ml (Sm200);
ampicillin, 100 μg/ml (Ap100) for E. coli and Vibrio strains;
chloramphenicol, 20 μg/ml (Cm20) for E. coli and 5 μg/ml
(Cm5) for P. inhibens and Vibrio strains; kanamycin, 50 μg/
ml (Km50) for E. coli strains and 200 μg/ml (Km200) for P.
inhibens; and tetracycline, 15 μg/ml (Tc15) for E. coli and
1 μg/ml (Tc1) for V. anguillarum. Frozen stocks in glycerol
were maintained at −74 °C and cultures were routinely
identified by phenotypic and genotypic characteristics.
Insertional mutagenesis
Insertional mutagenesis by homologous recombination
was used to create interruptions within specific genes
using a modification of the procedure described by
Milton and Wolf-Watz [37, 38]. Primers (Table 4) were
designed to amplify specific Phaeobacter genes based on
homologous sequences from P. inhibens 2.10 (GenBank
accession No.CP002972.1) (Phaeobacter 2.10 was reclas-
sified into P. inhibens from P. gallaeciensis in 2013 [39]).
A fragment of the selected gene was PCR amplified, then
digested with SacI and XbaI restriction enzymes, and the
DNA fragments separated on a 1 % agarose gel. The gel-
purified PCR fragment was ligated into the suicide vec-
tor pNQ705 after digestion with SacI and XbaI and the
ligation mixture was introduced into E. coli Sm10 (λ pir)
by electroporation (0.2 cm cuvette, 2.5 kV, 200 Ω, 25 μF)
with Bio-Rad Gene Pulser II. Recombinant plasmids
were confirmed by both PCR amplification and sequen-
cing. The mobilizable suicide vector was transferred
from E. coli Sm10 (λ pir) into S4Sm by conjugation.
Transconjugants were selected by utilizing the chloram-
phenicol resistance gene located on the suicide plasmid.
The incorporation of the suicide vector into the gene of
interest was confirmed by PCR analysis and DNA se-
quencing of the mutated genes [37].
Complementation of mutants
P. inhibens mutants were complemented by cloning the
target gene fragment into the shuttle vector pBBR1MCS4
(GenBank accession No. U25060), using a modification of
the method by Rock and Nelson [40]. Primers (Table 4)
were designed with a SacI or XbaI site added to the 5′ end
of the appropriate primer. The primer pair was used to
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Table 3 Bacterial strains and plasmids used in this study
Strains or plasmids Description Resistance Reference
P. inhibens
S4 Previously Phaeobacter sp. S4; wild type isolate from the inner shell of oysters Karim et al., 2013
S4Sm Spontaneous Smr mutant of S4 Smr this study
WZ10 clpX insertional mutant of S4Sm Smr Cmr this study
WZ11 clpX+, clpX in trans complement of WZ10 Smr Cmr Apr this study
WZ20 exoP insertional mutant of S4Sm Smr Cmr this study
WZ21 exoP+, exoP in trans complement of WZ20 Smr Cmr Apr this study
WZ02 S4Sm (pRhokHi-2-ofp) Smr Cmr Kmr this study
WZ12 clpX, WZ10 (pRhokHi-2-ofp) Smr Cmr Kmr this study
WZ22 exoP, WZ20 (pRhokHi-2-ofp) Smr Cmr Kmr this study
V. tubiashii
RE22 Wild type isolate from oyster larvae Estes et al., 2004
RE22Sm Spontaneous Smr mutant of RE22 Smr this study
WZ103 RE22Sm (pRhokHi-2-gfp) Smr Apr this study
V. anguillarum
NB10 Wild type, serotype O1, clinical isolate from the Gulf of Bothnia Norqvist et al., 1989
NB10Sm Spontaneous Smr mutant of NB10 Smr this study
WZ203 NB10Sm (pSUP202P-PflaB-gfp) Smr Apr Tetr this study
R. crassostreae
CV919-312T Wild type isolate from a JOD-affected oyster Boettcher et al., 1999
CV919Sm Spontaneous Smr mutant of CV919-312 T Smr this study
E. coli
Sm10 thi thr leu tonA lacY supE recA RP4-2 Tc::Mu::Km (λpir) Kmr Simon et al., 1983
S100 Sm10 harboring pNQ705-1 this study
WQ10 Sm10 harboring pNQ705-clpX this study
WQ20 Sm10 harboring pNQ705-exoP this study
WB01 Sm10 harboring pBBR1MCS4 this study
WB11 Sm10 harboring pBBR1MCS4-clpX this study
WB21 Sm10 harboring pBBR1MCS4-exoP this study
S122 Sm10 harboring pSUP202P-gfp(ORF) this study
S136 Sm10 harboring pSUP202P-PflaB-gfp this study
W900 Sm10 harboring pRhokHi-2-FbFP this study
WR03 Sm10 harboring pRhokHi-2-gfp this study
WR02 Sm10 harboring pRhokHi-2-ofp this study
W901 Sm10 harboring pmOrange this study
Plasmids
pNQ705-1 Cmr; suicide vector with R6K origin Mcgee, 1996
pNQ705-clpX Cmr; derivative from pNQ705-1 for clpX insertional mutant this study
pNQ705-exoP Cmr; derivative from pNQ705-1 for exoP insertional mutant this study
pBBR1MCS4 Apr; derivative from pBBR1MCS (a broad-host-range cloning vector) Kovach et al., 1995
pBBR1MCS4-clpX Apr; derivative from pBBR1MCS4 for clpX in trans complement this study
pBBR1MCS4-exoP Apr; derivative from pBBR1MCS4 for exoP in trans complement this study
pBS(gfp)-Pcampy Template for gfp ORF PCR amplification Eggers et al., 2004
pCE320(gfp)-PflaB Template for PflaB PCR amplification Eggers et al., 2004
Zhao et al. BMC Microbiology  (2016) 16:1 Page 12 of 17
amplify the entire gene plus ∼ 500 bp of the 5′ and 3′
flanking regions from genomic DNA sequences of P.
inhibens 2.10 (GenBank accession No.CP002972.1). The
resulting amplicon was ligated into the pBBR1MCS4 plas-
mid after digestion with SacI and XbaI and the ligation
mixture introduced into E. coli Sm10 (λ pir) by electropor-
ation with Bio-Rad Gene Pulser II. Transformants were
selected on LB10-Amp100 agar plates and the recombin-
ant plasmids confirmed by both PCR amplification and
sequencing. The complementing plasmid, pBBR1MCS4-
clpX or pBBR1MCS4-exoP, was transferred from E. coli
Sm10 into clpX or exoP mutants by conjugation using the
procedures described previously [37, 41]. The transconju-
gants were confirmed by PCR amplification.
Fluorescence tagging of P. inhibens strains and Vibrio
species
P. inhibens strains were tagged by pRhokHi-2-OFP and V.
tubiashii was tagged by pRhokHi-2-GFP. The orange
fluorescence protein gene (ofp) and the green fluorescence
protein gene (gfp) were PCR amplified by using the appro-
priate primer pair (Table 4) designed according to the se-
quence of pmOrange vector (Clontech) and pSUP202p/
PflaB-gfp vector. The PCR product was digested with
NdeI and BamHI restriction enzymes and the DNA frag-
ments separated on a 1 % agarose gel. Subsequently, the
gel-purified ofp or gfp PCR fragment was ligated into
pRhokHi-2 after digestion with NdeI and BamHI and the
ligation mixture was introduced into E. coli Sm10 (λpir)
Table 3 Bacterial strains and plasmids used in this study (Continued)
pSUP202P Apr Cmr Tcr; broad host shuttle vector Simon et al., 1983
pSUP202P-gfp(ORF) Apr Tcr; derivative from pSUP202 for GFP tagging this study
pSUP202P-PflaB-gfp Apr Tcr; derivative from pSUP202 for GFP tagging this study
pRhokHi-2-FbFP Cmr Kmr; derivative from pBBR1MCS (a broad-host-range cloning vector)
with promoter PaphII
Piekarski et al., 2009
pRhokHi-2-gfp Cmr Kmr; derivative from pRhokHi-2-FbFP with gfp under the control of PaphII this study
pmOrange Template for ofp ORF PCR amplification Clontech Laboratories, Inc.
pRhokHi-2-ofp CmrKmr; derivative from pRhokHi-2-FbFP with ofp under the control of PaphII this study
Table 4 Primers used in this study
Primer Sequence (5′ to 3′, underlined sequences are engineered restriction sites) Description
pw30 GTATTAGAGCTCATCGCACTGCTTCTTGAGGT For tdaA insertional mutation, forward, with SacI site
pw31 CGACTATCTAGAGATGATTGGGTCCTTTGCAC For tdaA insertional mutation, reverse, with XbaI site
pw32 GTATTAGAGCTCAGCAGCCATGAATAGCCTGT For tdaB insertional mutation, forward, with SacI site
pw33 CGACTATCTAGAGGGTATCGGATTTCGGATTT For tdaB insertional mutation, reverse, with XbaI site
pw36 GTATTAGAGCTCATCTTTGGCTCCATCGACAT For tdbD insertional mutation, forward, with SacI site
pw37 CGACTATCTAGAGCACATTGTTGGGAAACTGA For tdbD insertional mutation, reverse, with XbaI site
pw108 GAAGAGCTCGGACGACTATGTGATTGGTCAGGC For clpX insertional mutation, forward, with SacI site
pw109 GGGTCTAGACGACGTTATATTCCGACGCCTGCA For clpX insertional mutation, reverse, with XbaI site
pw153 GTATTAGAGCTCGAGCATAACCGCTTTGCCCGCCGCCCA For exoP insertional mutation, forward, with SacI site
pw154 CGACTATCTAGACCATGCTGAGTGCAAGGTTGACGGCGG For exoP insertional mutation, reverse, with XbaI site
pw127 GCATTAGAGCTCGTCAGATTGGCCGAAGCCCCTTTT For clpX in trans complement, forward, with SacI site
pw128 CGGCTATCTAGACGAACTCACCACCTGAGGAGATACGT For clpX in trans complement, reverse, with XbaI site
pw166 GTATTAGAGCTCCCCGTCCGATGTGTCAAAATAGGT For exoP in trans complement, forward, with SacI site
pw165 CGTCTTTCTAGAGGTGCCTGCGGTCATCACCATGAC For exoP in trans complement, reverse, with XbaI site
pwGFP-F GCGGTACATATGTAAGGAGGAAAAACATATG For amplification of gfp ORF, forward, with NdeI site
pwGFP-R CTATATGGATCCCAGATCTATTTGTATAGTTCATCCA For amplification of gfp ORF, reverse, with BamHI site
Pm113 GGTACCTGTCTGTCGCCTCTTGT For amplification of PflaB, forward, with KpnI site
Pm114 GGTACCATATCATTCCTCCATGAT For amplification of PflaB, forward, with KpnI site
pwmO-F GCGGTACATATGATGGTGAGCAAGGGCGAGGAGAAT For amplification of ofp ORF, forward, with NdeI site
pwmO-R CTATATGGATCCCTTGTACAGCTCGTCCATGCCGCC For amplification of ofp ORF, reverse, with BamHI site
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by electroporation with Bio-Rad Gene Pulser II. Transfor-
mants were selected on LB10-Cm20 agar plates. All plas-
mids were transferred from E. coli SM10 to recipient
strains of P. inhibens S4Sm,V. tubiashii RE22Sm, R. crassos-
treae CV919Sm, and V. anguillarum NB10Sm using the
method described previously by Mou et al. [41]. The trans-
conjugants were confirmed by fluorescence microscopy.
Biofilm formation
Biofilm formation was assessed using a modification of
the crystal violet (CV) staining method [19]. Bacteria
were grown for 2 days in YP30 (27 °C with shaking) to
stationary phase (2 × 109 CFU/ml). Cells (2 μl) were
transferred into 2 ml of fresh YP30 broth in 30 mm ×
100 mm borosilicate (Pyrex) glass culture tubes contain-
ing 2 ml YP30 broth and allowed to grow at 27 °C with-
out shaking. When sampling, the liquid culture was
discarded and each tube rinsed twice with NSS to re-
move loosely attached cells. The biofilm attached to the
test tube wall was stained with 2 ml of CV solution
(0.2 %) for 20 min at room temperature. Unbound dye
was removed with two washes of NSS. The bound dye
was eluted with 95 % (vol/vol) ethanol for 30 min and
then the amount of eluted crystal violet was measured
by spectroscopy at 580 nm using a VERSA-MAX micro-
plate reader.
Inhibition zone assay
Anti-bacterial activity of P. inhibens strains was mea-
sured by a growth inhibition assay using V. anguillarum,
V. tubiashii, and R. crassostreae as the target organisms.
An aliquot (100 μl) from a stationary phase overnight
culture of the appropriate Vibrio or R. crassostreae cul-
ture (2 × 109 CFU/ml) was spread onto YP30 agar plates,
then 10 μl of a 2-day-old culture (2 × 109 CFU/ml) of a
P. inhibens strain was spotted in triplicate onto the
pathogen cell lawn. After incubation at 27 °C for 24 h,
the level of antibacterial activity was determined by the
diameter of the inhibition zone around the P. inhibens
colonies.
P. inhibens culture supernatant killing assay
In order to determine the bactericidal activity of culture
supernatants, P. inhibens strains were grown for 2 days in
YP30 (27 °C with shaking). Cultures were centrifuged
(8000 × g, 10 min) and filtered through 0.2 μm pore mem-
brane filters to collect filter sterilized cell-free superna-
tants. Overnight cultures of V. anguillarum (NB10Sm)
cells (2 × 109 CFU/ml) were then serially diluted in filter
sterilized, cell-free P. inhibens culture supernatant ob-
tained from the various strains of P. inhibens or NSS, and
then spotted (10 μl/spot of diluted V. anguillarum cells)
in triplicate onto YP30 plates. All experiments were re-
peated twice. Killing percentage was calculated as follows:
Killing % = [(no. of colonies in NSS control) – (no. of
colonies in S4 supernatant treated)/(no. of colonies in
NSS control)] × 100.
Glass coverslip colonization competition assay between P.
inhibens strains and V. tubiashii WZ103 or V. anguillarum
WZ203
This assay was performed using a modification of estab-
lishment and invasion of pre-established biofilms method
[42]. For all competition experiments, P. inhibens strains
(S4Sm, clpX mutant and exoP mutant) were grown for
2 days in YP30 (27 °C with shaking) to stationary phase.
Cells were harvested by centrifugation, washed twice in
NSS, resuspended in fresh YP30, and then transferred into
6-well plates (Costar, Tewksbury MA). Each well con-
tained a glass coverslip, 4 ml YP30 broth supplemented
with streptomycin, and was inoculated with the appropri-
ate P. inhibens strain (WZ02, WZ12, or WZ22) tagged
with orange fluorescence protein (OFP) (final concen-
tration ~1 × 104 CFU/ml). For experiments examining the
effects of pretreatment with P. inhibens, after 24 h incuba-
tion at 27 °C with no shaking (pretreatment with P. inhi-
bens) all coverslips were washed twice with NSS. Each
coverslip was transferred into a fresh well containing 4 ml
of YP30 broth supplemented with streptomycin plus the
green fluorescence protein (GFP)-tagged V. tubiashii
WZ103 or GFP-tagged V. anguillarum WZ203 (final con-
centration ~1 × 105 CFU/ml). After another 24 h incuba-
tion at 27 °C with no shaking, all coverslips were removed,
washed twice on a rotary shaker (LAB-LINE instrument,
Inc.) for 2 min (200 rpm) with NSS, and then transferred
into clean wells with fresh YP30 broth and allowed to in-
cubate as before. Two coverslips were removed at each
sampling time (24, 48, 72 h). One was used for determin-
ation of the cell density of the strains on the coverslip; the
second one was used for confocal imaging. Glass cover-
slips were washed with NSS twice on a rotary shaker for
2 min. After draining excess water, coverslips used for
confocal imaging were placed on depression slides and
cells on the upside of coverslip were wiped off with Kim-
wipes™. Coverslips used for CFU determinations were
immersed in 50 ml plastic tubes containing 10 ml NSS
and glass beads (0.5 g, 1 mm), then vortexed for 1 min.
Cell densities (CFU/ml) in the wells or suspended from
the coverslip were determined by serial dilution and spot
plating. Appropriate antibiotics were used for selection of
bacteria (see Table 3 for antibiotic resistances for each
strain). For experiments without pretreatment with P.
inhibens, all procedures were identical to those described
above except that GFP-tagged V. tubiashii WZ103 or V.
anguillarum WZ203 were added at the same time as
OFP-tagged P. inhibens. In the V. anguillarum competi-
tion experiments, both P. inhibens and V. anguillarum
were inoculated at ~106 CFU/ml.
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Effects of TDA supplementation on pathogen growth in a
co-culture system containing the clpX mutant and a Vibrio
species
OFP-tagged P. inhibens strains (S4Sm, clpX mutant)
grown for 2 days in YP30 (27 °C with shaking) to sta-
tionary phase, cells were transferred into 6-well plates.
Each well was inoculated with the appropriate OFP-
tagged P. inhibens strain (initial concentration at ~
104 CFU/ml) in 4 ml of YP30 broth supplemented with
the appropriate antibiotic and one glass coverslip. After
24 h incubation (pre-treatment with P. inhibens), all cov-
erslips were washed twice in NSS. Each coverslip was
transferred into a clean well containing 4 ml YP30 broth
and either GFP-tagged V. anguillarum WZ203 or V.
tubiashii WZ103 at a concentration of ~ 105 CFU/ml
plus TDA (5 μg/ml for V. anguillarum WZ203 or 10 μg/ml
for V. tubiashii WZ103; based on calculated MIC). The
biofilms on the coverslips were imaged as described below
and cell densities were determined as described above.
Laser confocal scanning microscopy
Laser confocal scanning microscopy was performed in the
Rhode Island Genomic Sequencing Center using a Zeiss
AxioImager 2 microscope equipped for digital image acqui-
sition with a Zeiss AxioCam HRc high-resolution camera
and for laser scanning microscopy with a Zeiss LSM 700
confocal module. The confocal module is equipped with
four diode lasers with excitation lines at 405, 488, 555, and
639 nm and utilizes the Zeiss ZEN 2011 software.
Challenge trials
Oyster larvae (n = 21–28 per well, veliger stage, ~0.060–
0.150 mm in diameter) were placed in wells of a 6-well
plate containing 5 ml of sterile filtered seawater (28
psu). Overnight cultures of P. inhibens strains grown in
YP30 (~109 CFU/ml) were added to a final concentra-
tion of ~104 CFU/ml. Plates were incubated at 20 °C for
24 h with shaking. Water was changed and V. tubiashii
RE22 was added at a concentration of ~105 CFU/ml in
seawater and incubated for an additional 24 h before
counting living and dead oysters. Oyster larvae treated
only by artificial seawater served as control. The survival
rate was calculated by using the formula: Survival rate
(%) = 100 x (number of live larvae/total number of
larvae). These experiments were run at least 2 times in
triplicate [16]. As invertebrates, oysters are exempt from
approval from the University of Rhode Island Institu-
tional Animal Care and Use Committee.
Statistical analysis
Data are expressed as means ± standard deviation (SD).
Two-tailed, unpaired Student’s t tests were used for stat-
istical analyses for all experiments, and P values of <0.05
were considered statistically significant.
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Additional file 1: A) Electrospray ionization MS of purified TDA,
structure shown on right, in the positive ion mode. The spectrum
shows expected losses of H2O and CO2H. (PDF 64 kb)
Additional file 2: 1H NMR spectrum (500 MHz, C6D6) for purified
TDA. The spectrum is expanded to show the aromatic region of interest.
Spectrum was referenced to residual benzene resonance at 7.16 ppm.
(PDF 110 kb)
Additional file 3: 1H NMR spectroscopic data of purified TDA from
P. inhibens. Comparison is provided to data published by Liang (2003).
(PDF 7 kb)
Additional file 4: A) Reversed-phase HPLC chromatograms of ethyl
acetate extracts from Phaeobacter S4 mutant strains. B) Quantification
of biofilm formation by measuring OD580 of crystal violet dye attached
to the cells forming biofilms on glass tubes at 27 °C under static
condition. The data presented are average of two independent
experiments and each independent experiment has three replicates.
Error bars represent one standard deviation. (PDF 83 kb)
Additional file 5: Growth curve of Phaeobacter S4 strains under
different conditions (static vs. shaking). Overnight culture of
Phaeobacter cells were grown in YP30 media and then back-diluted into
fresh YP30 1:1000 dilution. Samples were taken at the indicated times
and OD600 value were measured by a spectroscopy. Error bars represent
one standard deviation. (PDF 340 kb)
Additional file 6: Effects of V. anguillarum NB10 on the growth of P.
inhibens strains in a competition assay without pre-colonization by
P. inhibens. The mixed cultures are: S4Sm-OFP with NB10Sm-GFP, clpX-
OFP with NB10Sm-GFP and exoP-OFP with NB10Sm-GFP. Colonization
and initial cell densities were as described in the Materials and Methods.
A) Growth of sessile P. inhibens cells (with NB10Sm) in a co-culture system
and a monoculture control. B) Growth of planktonic P. inhibens cells (with
NB10Sm) in a co-culture system and a monoculture control. The data
presented are average of two independent experiments and each
independent experiment has three replicates. Error bars represent one
standard deviation. (PDF 362 kb)
Additional file 7: Competition assay between P. inhibens S4Sm
strains and V. anguillarum NB10Sm without pre-colonization by P.
inhibens. The mixed cultures are S4Sm-OFP with NB10Sm-GFP, clpX-OFP
with NB10Sm-GFP and exoP-OFP with NB10Sm-GFP. A) Single channel
and merged confocal microscopy images of mixed biofilm development
by OFP-producing strains (S4Sm, clpX mutant or exoP mutant) and
GFP-producing V. anguillarum NB10Sm-GFP on the surface of glass coverslip
at 48 h. The data presented is from a representative experiment of two
independent experiments. B) Growth of sessile NB10Sm in co-culture system
with different Phaeobacter strains. C) Comparison of growth of sessile V.
anguillarum (NB10Sm) in different co-culture system and monoculture
control. D) Growth of planktonic V. anguillarum (NB10Sm) in co-culture
system with different Phaeobacter strains. E) Comparison of growth of
planktonic V. anguillarum (NB10Sm) in different co-culture system and
monoculture control. The data presented are average of two independent
experiments and each independent experiment has three replicates. Error
bars represent one standard deviation. (PDF 1811 kb)
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